SHERIDAN, Wyo., Sept. 8, 2026 /PRNewswire/ -- The global pharmaceutical CDMO market is projected to grow from USD 191 billion in 2026 to USD 270.3 billion by 2031, registering a CAGR of 7.2% during the forecast period (2026–2031), according to a new study by Wissen Research.

Growth in the pharmaceutical CDMO market is being driven by rising outsourcing of drug development and manufacturing by pharmaceutical and biotechnology companies, growing demand for biologics and complex therapeutics, and continuous advancements in manufacturing technologies. Pharmaceutical contract development and manufacturing organizations (CDMOs) are expanding their capabilities across small molecules, biologics, cell and gene therapies, and specialized dosage forms — supporting drug development in oncology, rare diseases, infectious diseases, and personalized medicine — while enabling pharmaceutical companies to optimize their supply chains and focus resources on core R&D.

Get a Report Tailored to Your Specific Business Needs:

https://www.wissenresearch.com/request-customization/?report=pharmaceutical-cdmo-market

Where Manufacturing Technology Is Heading

Advances in bioprocessing, continuous manufacturing, and process analytical technologies (PAT) are giving today's CDMOs far more precise control over drug development and manufacturing than a decade ago. The adoption of single-use technologies, automation, digital twins, and AI-based process optimization is improving manufacturing flexibility, lowering contamination risk, and speeding up delivery timelines for both small-molecule and biopharmaceutical products.

At the same time, rising demand for complex drug classes — including biologics, cell and gene therapies, antibody-drug conjugates (ADCs), and mRNA-based medicines — is pushing CDMOs to build out increasingly specialized manufacturing platforms and analytics capabilities. As outsourcing becomes a bigger part of how pharmaceutical companies bring drugs to market, technology-driven CDMOs are becoming central players in the broader pharmaceutical supply chain rather than peripheral service providers.

What's Fueling Growth in the Pharmaceutical CDMO Market

- Rising Outsourcing Activity: Pharmaceutical and biotechnology firms are increasingly outsourcing manufacturing to save on capital costs, optimize production, and keep internal focus on drug discovery and commercialization.

- Growing Demand for Complex Therapeutics: Rising need for biologics, biosimilars, cell and gene therapies, ADCs, and mRNA therapeutics is driving demand for CDMOs with specialized development and manufacturing expertise.

- Increasing Regulatory Complexity: Growing intricacy of regulatory compliance and quality standards is pushing drug makers toward CDMOs with strong compliance expertise and global regulatory support capabilities.

- Expanding Drug Pipelines: A growing pipeline of drugs and rising number of clinical trials are increasing demand for end-to-end solutions spanning development, scale-up, manufacturing, packaging, and distribution.

- Investment in Advanced Manufacturing: Growing adoption of single-use bioprocessing, automation, and continuous manufacturing technologies is helping CDMOs improve efficiency and reduce speed-to-market for pharmaceutical clients.

Schedule a call with our lead analyst: https://www.wissenresearch.com/contact/

Key Constraints in the Pharmaceutical CDMO Industry

Operating a pharmaceutical CDMO business requires continuous investment in quality systems, facility upgrades, and regulatory expertise to meet strict requirements from agencies such as the U.S. FDA and European Medicines Agency (EMA). Rising demand for biologics and advanced therapies has also placed pressure on manufacturing capacity, particularly for specialized facilities capable of handling sterile injectables, high-potency drug manufacturing, and cell and gene therapy production — and limited availability of such qualified facilities can lengthen production timelines and raise costs for pharmaceutical clients.

Supply chain complexity, high capital investment requirements, and dependence on skilled technical talent add further pressure. Maintaining consistent regulatory compliance across multiple regions remains an ongoing operational challenge for CDMO providers operating on a global scale.

Industry Momentum: Capacity Expansion and Advanced Therapy Investment

Leading CDMOs including Lonza, Thermo Fisher Scientific, Catalent, Samsung Biologics, and WuXi AppTec continue to expand manufacturing capacity and strengthen integrated development-to-commercialization service offerings. Much of this investment is concentrated in biologics and advanced therapy manufacturing — including single-use bioprocessing, viral vector manufacturing, fill-finish operations, and high-containment facilities — as CDMOs position themselves to support the commercialization of next-generation therapies.

Asia-Pacific in particular is seeing accelerated capacity build-out, with companies such as WuXi Biologics, Samsung Biologics, and Syngene International expanding facilities to serve growing regional and international outsourcing demand.

Key Insights from Pharmaceutical CDMO Market Analysis

- The commercial segment led the market by operation type in 2025, driven by the growing number of approved drugs requiring large-scale manufacturing and rising outsourcing by pharmaceutical companies.

- The API (Active Pharmaceutical Ingredient) segment held the largest revenue share by product type in 2025, supported by rising demand for high-potency and complex APIs.

- North America is the largest regional market, supported by a dense concentration of pharmaceutical companies and advanced manufacturing infrastructure.

- Asia-Pacific is the fastest-growing region, with China in particular projected to see significant growth during the forecast period, driven by an expanding manufacturing base, favorable government initiatives, and competitive production costs.

- Chinese CDMOs including WuXi AppTec, Asymchem, Porton Pharma Solutions, and Pharmaron continue to expand research, development, and manufacturing capabilities to serve both domestic and international pharmaceutical companies.

Key Players in the Pharmaceutical CDMO Market

Leading companies in the pharmaceutical CDMO market are focused on capacity expansion, biologics manufacturing capability, and integrated end-to-end service offerings to strengthen their competitive position.

Regional Analysis and Growth Opportunities in the Pharmaceutical CDMO Market

North America holds the largest share of the pharmaceutical CDMO market, underpinned by a strong concentration of pharmaceutical and biotechnology companies, advanced manufacturing infrastructure, and mature regulatory frameworks that support faster drug commercialization.

Asia-Pacific is the fastest-growing region, propelled by expanding pharmaceutical manufacturing infrastructure, competitive production costs, skilled scientific talent, and favorable government initiatives across China, India, South Korea, and Singapore. China in particular is expected to see significant growth during the forecast period, supported by rapidly growing domestic pharmaceutical and biotechnology industries and improving regulatory quality standards.

Europe, Latin America, and the Middle East & Africa complete the report's regional coverage, with growth tied to rising outsourcing activity and expanding biologics manufacturing investment.

Product & Operation Type Insights

By product type, API manufacturing held the largest revenue share in 2025, driven by rising demand for high-potency APIs (HPAPIs), peptide APIs, and complex small molecules. Major CDMOs including Lonza, Cambrex, Siegfried, WuXi STA, and CordenPharma continue to invest in expanding API manufacturing capacity, supported by rising demand for oncology therapeutics, specialty medicines, and biologics.

By operation type, the commercial segment led the market in 2025, as pharmaceutical companies increasingly outsource large-scale, commercial manufacturing to reduce capital investment and accelerate product commercialization — a trend reinforced by continued expansion of biologics manufacturing capacity and growing approval of specialty drugs.

Get the Complete Pharmaceutical CDMO Market Report — Forecasts, Insights & Growth Opportunities: https://www.wissenresearch.com/market-research-reports-pricings/pharmaceutical-cdmo-market

Market Segmentation Snapshot

The global pharmaceutical CDMO market is segmented across product, dosage form, operation, therapeutic area, end user, and region:

- By Product: 

- Pharmaceutical Manufacturing Services (API Manufacturing, Finished Dosage Formulation Manufacturing)

- Pharmaceutical Drug Development Services

- Biologics Manufacturing Services

- Packaging & Labelling Services

- Fill-Finish Services

- Other Services

- By Dosage Form: 

- Solid (Capsules, Tablets, Powder)

- Semi-Solid (Paste, Cream, Gel)

- Liquid (Injectable/Parenteral, Suspensions, Emulsion, Others)

- Others

- By Operation Type: 

- Clinical

- Commercial

- By Therapeutic Area: 

- Oncology

- Infectious Diseases

- Neurological Disorders

- Cardiovascular Diseases

- Metabolic Disorders

- Autoimmune Diseases

- Respiratory Diseases

- Others

- By End User: 

- Small Pharmaceuticals

- Mid-Sized Pharmaceuticals

- Large Pharmaceuticals

- By Region: 

- North America

- Europe

- Asia-Pacific

- Latin America

- Middle East & Africa

As outsourcing becomes a structural part of how pharmaceutical companies bring complex drugs to market, and as CDMOs continue investing in biologics, cell and gene therapy manufacturing, and advanced process technologies, the pharmaceutical CDMO market is set to remain a critical enabler of drug development and commercialization worldwide.

Coffman Stair Parts Names John Sowatsky President, Completing New Leadership Team

ATLANTA, Sept. 8, 2026 /PRNewswire/ -- Coffman Stair Parts, a leader in residential stair parts distribution and custom manufacturing, announced the appointment of John Sowatsky as President, effective Sept. 1. The appointment completes a leadership team that the Company has built over the past year, following the additions of Tim Short as Director of Finance and Accounting in December 2025 and Erik Wilke as Vice President of Sales in February 2026.

John Sowatsky becomes President after serving as Chief Operating Officer and will lead the Company's continued growth with a strong emphasis on the expansion of its custom wood manufacturing operation. He brings a supply chain background built in the automotive industry and carried into construction products distribution. Prior to joining Coffman, he served as Vice President of Supply Chain at Grabber Construction Products, where he led sourcing, inventory, and distribution. Sowatsky holds a Bachelor's degree in Supply Chain Management from Michigan State University.

Erik Wilke joined as Vice President of Sales, where he leads the national sales organization and dealer and builder channel strategy. He brings extensive experience in sales leadership, business development, and distribution within the building materials industry. Before Coffman, he served as Director of Sales at Wurth Wood Group where he provided strategic leadership across sales and business operations, with a focus on customer growth, market development, and key customer relationships. Prior to Wurth, he held progressive sales and leadership roles at Fastenal. Wilke holds an MBA from North Greenville University and a Bachelor's degree in Accounting from Lander University.

Tim Short joined as Director of Finance and Accounting, overseeing financial reporting, planning, and cost management across the Company's manufacturing and distribution operations. He previously served as Corporate Controller at Swan Products, where he was responsible for treasury management, full cycle accounting, financial reporting, and costing. Prior to Swan Products, he held roles of increasing size and scope as a finance leader within Sherwin-Williams' manufacturing and distribution division. Short holds a Master's degree in Accounting from Ohio State University and a Bachelor's degree in Accounting from Ohio Northern University.

"Coffman has been supplying stair parts for 150 years, and our customers expectations have never been higher — right product, right place, right time. With this team in place, we can deliver that across the business, from stock distribution to custom manufacturing and finishing," said John Sowatsky, President of Coffman Stair Parts.

ABOUT COFFMAN STAIR PARTS

Founded in 1874, Coffman Stair Parts is one of the largest distributors and manufacturers of residential stair parts in the United States, serving lumberyards, dealers, stair builders, installers, and home improvement retailers. The Company is headquartered in Austell, Georgia, with distribution facilities in Edison, New Jersey; Taneytown, Maryland; and Plano, Texas. The Company also has a facility in Little Falls, New York that provides custom wood manufacturing and finishing to order alongside the Company's standard catalog program.

SOURCE Broadview Group

Share this article

DELRAY BEACH, Fla., Sept. 8, 2026 /PRNewswire/ -- According to MarketsandMarkets™, the Laboratory Mixers Market is projected to reach USD 2.74 billion by 2031 from USD 2.27 billion in 2026, at a CAGR of 3.5% during the forecast period.

Browse 200 market data Tables and 70 Figures spread through 250 Pages and in-depth TOC on "Laboratory Mixers Market- Global Forecast to 2031"

Laboratory Mixers Market Size & Forecast:

- Market Size Available for Years: 2026–2031

- 2026 Market Size: USD 2.27 billion

- 2031 Projected Market Size: USD 2.74 billion

- CAGR (2026–2031): 3.5%

Laboratory Mixers Market Trends & Insights:

- By region, the Asia Pacific laboratory mixers market is projected to witness a CAGR of 6.5% from 2026 to 2031.

- By product, the shakers segment is expected to register a CAGR of 5.0% during the forecast period.

- By mode of operation, the gyratory mixers segment is expected to register a CAGR of 5.5% during the forecast period.

Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=163287347

Global demand for laboratory mixers is supported by the expansion of research laboratories, pharmaceutical and biotechnology development, clinical testing, food and environmental analysis, and higher-throughput sample-preparation workflows. Mixers are used across these settings for reagent preparation, sample resuspension, cell culture, extraction, formulation, assay development, and quality-control testing. Demand is therefore closely linked to laboratory capacity, research funding, new facility construction, equipment replacement, and the adoption of more standardized and automated procedures.

Shakers to account for the largest share of the laboratory mixers market in 2031.

Based on product, the shakers segment is expected to capture the largest market share in 2031, as they serve multiple high-volume research and biopharmaceutical workflows, while magnetic stirrers benefit from broader routine use and strong replacement demand. Shakers are used for continuous, controlled movement in cell culture, sample preparation, bacterial and yeast growth, hybridization, staining, solubility testing, and incubation. Orbital and incubator shakers are particularly important in cell-based research because they help maintain uniform nutrient distribution and oxygen transfer in suspension cultures. They are used for bacterial, yeast, fungal, mammalian, and insect-cell cultivation, including cell expansion, plasmid and protein expression, media development, and inoculum preparation. These applications are more equipment-intensive and often involve higher-value products than routine tube mixing. Customers may require temperature control, carbon dioxide control, programmable operation, larger platforms, stackable systems, or specialized clamps and flask holders. This creates greater revenue potential per unit than basic vortex mixers or standard magnetic stirrers.

Pharmaceutical & biotechnology companies segment to record the highest CAGR from 2026 to 2031.

Based on end user, the pharmaceutical & biotechnology companies segment is projected to witness the fastest growth during the forecast period. There has been increased drug-discovery and R&D activity. Drug formulation, analytical development, stability testing, dissolution work, assay preparation, and sample preparation require repeatable mixing. Monoclonal antibodies, recombinant proteins, vaccines, and other biologics rely on cell culture, media preparation, buffer preparation, and gentle, uniform agitation. These workflows require orbital shakers, incubator shakers, rockers, rollers, magnetic stirrers, and single-use mixers. This shows measurable demand potential for mixers in biologics manufacturing. Cell therapy, gene therapy, stem-cell research, and regenerative medicine require tightly controlled cultivation and sample-preparation conditions. Incubator shakers and automated cell shakers support oxygen transfer, cell suspension, temperature control, and reproducible growth conditions. This creates promising demand for mixers in cell and gene therapy applications. All these factors are projected to help pharmaceutical and biotechnology companies show significant growth during the forecast period.

Inquiry Before Buying: https://www.marketsandmarkets.com/Enquiry_Before_BuyingNew.asp?id=163287347

North America to hold the largest share of the laboratory mixers market in 2031.

North America is projected to account for the largest market share in 2031, owing to the large concentration of research universities, biomedical institutes, pharmaceutical and biotechnology companies, CROs, clinical laboratories, and advanced testing facilities. These end users require laboratory mixers across routine sample preparation, cell culture, reagent and buffer preparation, assay development, formulation work, analytical testing, and quality-control operations. The region has a mature research and funding ecosystem that supports purchases of laboratory equipment through university research grants, public research programs, shared-core facilities, and institutional procurement channels. This creates a large installed base of vortex mixers, magnetic stirrers, shakers, thermal mixers, and overhead stirrers. It also supports recurring replacement demand as laboratories upgrade equipment for improved reliability, digital control, temperature management, and compatibility with microplates, tubes, and automated workflows.

Key Players

Leading players in the Laboratory Mixers companies include Thermo Fisher Scientific (US), Avantor, Inc. (US), Bio-Rad Laboratories (US), Eppendorf SE (Germany), and Corning Incorporated (US).

Get 10% Free Customization on this Report: https://www.marketsandmarkets.com/requestCustomizationNew.asp?id=163287347

Laboratory Mixers Market - Investment & funding +Merger & Acquisition

Investment Funding Context

The laboratory mixers market is influenced by investment across the broader laboratory-equipment and life-science-tools ecosystem rather than by standalone funding activity focused exclusively on mixers. Capital deployment in pharmaceutical and biotechnology R&D, biopharmaceutical manufacturing, clinical research, diagnostics, laboratory automation, and academic research infrastructure is driving the construction and modernization of laboratories worldwide.

Revenue Shift Context

The laboratory mixers market is experiencing a gradual revenue shift from basic, manually operated benchtop equipment toward higher-value systems that offer greater process control, versatility, and workflow compatibility. Traditional vortex mixers, magnetic stirrers, orbital shakers, and overhead stirrers continue to represent a key portion of unit sales as they are widely used in academic laboratories, hospitals, diagnostic centers, industrial quality-control facilities, and pharmaceutical laboratories. However, growth in revenue is increasingly concentrated in digitally controlled, temperature-managed, multi-position, and application-specific mixer platforms.

Mergers and Acquisitions

Mergers/acquisitions in the laboratory mixers market for 2025 and 2026 are at a measurable pace and can outpace past years. Key players have shown activity in the inorganic space, covering agreements, partnerships, and collaborations.

LABORATORY MIXERS MARKET: MERGERS AND ACQUISITIONS, JANUARY 2024–JANUARY 2026

Company Revenue Share Details

The laboratory mixers market is characterized by a competitive structure, comprising multinational laboratory-equipment suppliers, specialized mixer manufacturers, regional producers, and distributors. Key companies include Thermo Fisher Scientific, Eppendorf, IKA-Werke, Avantor, Bio-Rad Laboratories, Corning, Antylia Scientific, and Heidolph. Limited companies appear to show leading positioning in the market as laboratory mixers encompass several product types—vortex mixers, magnetic stirrers, shakers, overhead stirrers, thermomixers, and specialized mixing systems—and suppliers often have strength in only selected categories. The competitive environment is therefore shaped less by broad corporate revenue and more by product breadth, application expertise, brand reputation, reliability, distributor coverage, after-sales service, and the ability to integrate equipment into automated and digitally enabled laboratory workflows.

Browse Adjacent Market: Analytical and Scientific Instrumentation Market Research Reports &Consulting

See More Latest Analytical and Scientific Instrumentation Reports:

Life Science Instrumentation Market by Technology (Spectroscopy, Chromatography, NGS, PCR, Microscopy, Centrifuge, Liquid Handling), Application (Diagnostic, Research), End User (Pharma-Biopharma, Food, Hospital, Academia, CRO) - Global Forecast to 2031

In Vitro Diagnostics Market by Product & Service (Kits, Instruments), Technology (Immunoassay, Hematology, Glucose Monitoring), Specimen (Blood), Site of Testing, Application (Endocrinology, Cardiology, Infectious Diseases) & Region- Global Forecast to 2030

About MarketsandMarkets™

MarketsandMarkets™ has been recognized as one of America's Best Management Consulting Firms by Forbes, as per their recent report.

MarketsandMarkets™ is a blue ocean alternative in growth consulting and program management, leveraging a man-machine offering to drive supernormal growth for progressive organizations in the B2B space. With the widest lens on emerging technologies, we are proficient in co-creating supernormal growth for clients across the globe.

Today, 80% of Fortune 2000 companies rely on MarketsandMarkets, and 90 of the top 100 companies in each sector trust us to accelerate their revenue growth. With a global clientele of over 13,000 organizations, we help businesses thrive in a disruptive ecosystem.

The B2B economy is witnessing the emergence of $25 trillion in new revenue streams that are replacing existing ones within this decade.

The article explains when four-slide stamping delivers greater efficiency, precision, and cost savings for complex metal parts.

ROCHESTER, N.Y., Sept. 8, 2026 /PRNewswire/ -- What is four-slide stamping, and when is it the best manufacturing choice?

HelloNation answers that question in a HelloNation article featuring insights from Precision Metal Stamping Expert Al Rogers of CAR Stamping & Machining in Rochester, New York. The article explains how four-slide stamping helps manufacturers produce intricate metal components more efficiently while maintaining consistent quality across large production runs.

The HelloNation article describes four-slide stamping as a specialized manufacturing process designed for producing small, detailed metal components that require multiple bends, forms, or other complex features. Unlike traditional stamping methods that often rely on multiple dies and additional finishing, the process uses four independently moving slides to shape metal from multiple directions in a single production cycle. This approach allows manufacturers to reduce production time while improving repeatability.

According to the article, four-slide stamping is especially valuable for producing complex metal parts that can be fully formed in a single operation. Electrical contacts, retaining clips, brackets, springs, fasteners, and medical device components are among the products commonly manufactured using this process. By completing multiple forming operations in a single cycle, manufacturers can reduce handling while maintaining tight dimensional tolerances for precision components.

The article explains that engineers evaluate several factors before selecting four-slide stamping for a project. Part geometry is one of the most important considerations because components with numerous bends, tabs, hooks, or other intricate features often benefit from this manufacturing process. Production volume also plays a significant role, as tooling investments become increasingly economical at high volumes, where faster cycle times and lower labor requirements can yield meaningful long-term savings.

Material selection is another important part of the decision-making process. The HelloNation article notes that four-slide stamping performs well with stainless steel, carbon steel, brass, copper, and several specialty alloys commonly used in precision metal stamping. Engineers evaluate material thickness, strength, and forming characteristics to ensure finished parts achieve the required shape while maintaining structural integrity and reliable performance.

The article also highlights the value of reducing secondary operations whenever possible. Eliminating additional machining, welding, or forming steps can streamline manufacturing while reducing opportunities for variation between finished parts. For companies producing thousands or millions of identical precision components, improved efficiency can shorten production schedules and lower overall operating costs without sacrificing consistency.

While the article outlines many advantages, it also explains that four-slide stamping is not the right solution for every application. Larger parts, deep-drawn components, or products requiring features beyond the capabilities of four-slide tooling may be better suited for progressive die stamping, transfer stamping, machining, or other fabrication methods. The article emphasizes that engineers compare manufacturing options based on part complexity, material requirements, tolerances, production volume, and overall cost before selecting the most appropriate process.

The article concludes that when a design matches the strengths of four-slide stamping, manufacturers can achieve an effective balance of precision, efficiency, and repeatability. By producing complex metal parts in a single operation while minimizing secondary operations, the process remains an important manufacturing solution for industries that depend on consistent, high-quality production. Precision Metal Stamping Expert Al Rogers provides industry knowledge that helps readers better understand how engineers determine when this specialized manufacturing process offers the greatest value.

"When Four-Slide Stamping Is the Best Manufacturing Choice" features insights from Al Rogers, a Precision Metal Stamping Expert in Rochester, New York, on HelloNation.

About HelloNation

HelloNation is America's Good News Network, a premier media platform built on the idea that good news travels faster when real people tell real stories. Through its community-focused publications and innovative "edvertising" approach, HelloNation delivers content that informs, inspires, and spotlights the leaders making a meaningful impact in their communities.

SOURCE HelloNation

Share this article

HO-3, HO-6, and DP-3 open for new business September 1, 2026, all three products live on day one on a single platform built for AI from the ground up, not retrofitted with it; commercial lines to follow in early 2027

TAMPA, Fla., Sept. 8, 2026 /PRNewswire/ -- Orange Insurance Exchange ("Orange") today announced it has gone live on Equinox™, the AI-native policy administration platform from Solstice Innovations, launching HO-3, HO-6, and DP-3 homeowners, condo, and dwelling fire products simultaneously for new business across its Florida portfolio. Orange's commercial lines products will launch on the same platform in early 2027.

Standing up three products at once, rather than staggering them over successive release cycles, reflects the core advantage of Equinox™: rating, issuance, endorsements, renewals, claims, billing, and forms all run on a single, holistic system, with AI embedded directly into the underwriting, servicing, and claims workflows rather than layered on top of them. The result is a platform Orange can reconfigure, rates, rules, forms, without waiting on a development calendar.

"We looked hard at what it would take to bring three products to market without compromising underwriting discipline," said Don Matz, Chief Executive Officer of Orange Insurance Exchange. "Solstice gave us a platform that's genuinely configurable, which means our underwriting team can respond to what we're seeing in the book instead of waiting on a release calendar. Our agents get a faster, cleaner submission process, and our members get decisions in a fraction of the time. Personal lines is the starting point; we're building our commercial product on the same foundation in early 2027."

The Equinox™ AI-native architecture is engineered into how the platform operates at every stage of the policy lifecycle, not bolted on as a standalone feature. At quote, it validates and enriches property data, cutting agent data entry and improving submission accuracy. In underwriting, it prioritizes referrals based on risk signals and classifies inspections, loss runs, and correspondence, freeing underwriters to focus on judgment rather than administrative review. Every capability operates within Orange's underwriting guidelines, with human oversight maintained for binding decisions. Additionally, Solstice has embedded AI throughout its entire SDLC, onboarding, and client support desk, improving the cadence, quality, and function of software delivery.

"There's a real difference between AI bolted onto a legacy system and AI that's woven into the DNA of the architecture from day one, that's the line we hold ourselves to," said Travis Pine, Chief Executive Officer of Solstice Innovations. "Orange came to us with a clear picture of how they wanted to underwrite and where the friction actually was. Standing up three products simultaneously on one configurable platform, with AI supporting the underwriter instead of replacing them, is exactly the kind of deployment Equinox™ was built for."

The launch extends the Equinox™ footprint across Florida homeowners and adds to a growing roster of carriers and MGAs, spanning NFIP flood, private flood, and homeowners lines, that have moved onto the platform in 2026. Solstice remains the only platform in the market unifying NFIP flood, private flood, and homeowners on a single AI-native system.

About Solstice Innovations

Solstice Innovations, Inc. (https://solstice.tech) delivers the leading AI-native policy administration platform for carriers and MGAs. Its flagship platform, Equinox™, brings intelligent automation, data-driven workflows, and multi-peril flexibility to NFIP flood, private flood, homeowners, commercial, and other P&C lines, built so AI is part of the system's architecture from the ground up, not added after the fact. Follow Solstice on LinkedIn (@Solstice Innovations) for updates.

Contact

Solstice Innovations Information

About Orange Insurance Exchange

Orange Insurance Exchange is a Florida-based reciprocal insurance exchange providing property insurance solutions through a network of independent insurance agents. Orange offers coverage for homeowners, condominium owners, landlords, and commercial residential property owners, combining disciplined underwriting, responsive service, and modern technology to deliver a better experience for agents and members. Orange is committed to building lasting relationships with its agency partners and serving Florida property owners with dependable coverage designed for the unique needs of the state's insurance market.

Contact

Orange Insurance Exchange

OrangeInsure.com

SOURCE Solstice Innovations, Inc.

Share this article

ADGM Reinforces Abu Dhabi's Standing as a Global Financial Hub with 54% Growth in AUM and Almost 14,000 Active Licences

ABU DHABI, UAE, Sept. 8, 2026 /PRNewswire/ -- ADGM, the international financial centre of Abu Dhabi, delivered strong growth in the first half of 2026, with Assets Under Management rising 54% year on year and its workforce reaching 49,027 professionals. Meanwhile, the number of active licences also climbed to almost 14,000.

The results reflect the continued expansion of capital, business activity and talent across ADGM, as global institutions increasingly structure, deploy and manage investment through Abu Dhabi. These results reinforce Abu Dhabi's growing position as the leading global financial hub of the MEASA region and the "Capital of Capital."

Commenting on another record performance by ADGM, His Excellency Ahmed Jasim Al Zaabi, Chairman of ADGM, said, "ADGM is championing Abu Dhabi's long-term economic vision and cementing its growing influence as the centre of global capital flows. The scale of growth we are witnessing across capital, institutions, businesses and talent demonstrates sustained international confidence in Abu Dhabi as a stable, trusted and globally connected financial hub. Whether it is capital, opportunity or ambition, Abu Dhabi is increasingly becoming the place where all these factors converge seamlessly and meaningfully. Through ADGM, we are building on this momentum, reinforcing Abu Dhabi's position as the Capital of Capital and advancing our ambition to become among the world's top five leading international financial centres."

ADGM's asset management ecosystem has sustained its strong momentum in 2026. AUM within ADGM increased 54% in H1 2026 compared to H1 2025, extending an unbroken run of growth since the start of 2022.

The number of fund and asset managers based in ADGM reached 190, up 23% from 154 in H1 2025, with 11 managers added in the second quarter alone, ADGM's strongest quarterly increase. The number of funds managed from ADGM rose to 276, representing a 32% increase from 209 funds in H1 2025.

Collectively, the asset managers that established operations in ADGM during H1 2026 oversee more than USD 2.1 trillion in global assets under management, underscoring Abu Dhabi's growing appeal as a destination for international investment firms.

ADGM continued to experience strong business activity during H1, with the total number of active licences reaching 13,974, making it the largest IFC in the MEASA region by this key indicator. Of these, 1,814 licences were issued during the period.

Operational entities reached 3,986, representing a 34% rise from 2,972 at the end of H1 2025, highlighting the continued evolution of ADGM from a destination for business establishment into an increasingly deep and active financial ecosystem.

ADGM's financial services ecosystem continued to deepen in H1 2026. The number of financial services entities operating within the jurisdiction surged to 392 in H1 2026, up 27% from 308 at the end of H1 2025.

Meanwhile, the Financial Services Regulatory Authority (FSRA) issued a total of 50 In-Principle Approvals for financial services firms, while 45 new Financial Services Permissions were granted.

Major financial firms establishing, launching or expanding their presence during the first half of the year included Capital Group, Man Group, Barings, Bain Capital, Hillhouse Investment, Muzinich & Co., Madison Realty Capital, Grow Investment Group, Rokos Capital Management, Polygreen Holdings, Hashed, Cantor, Bitexen MENA, Bitexen Custody, Copper ME, Blue Owl and Dhabi, among others.

The continued growth of ADGM's ecosystem is being matched by significant growth in its talent base.

At the end of H1 2026, the combined workforce across Al Maryah Island and Al Reem Island reached 49,027 professionals, an increase of 4,688 in the first half of 2026 alone. This represents an increase of 34%, compared to the same period last year.

ADGM Academy continued to advance Abu Dhabi's national talent and knowledge agenda during H1 2026, training 1,607 Emirati nationals and expanding pathways to employment through its partnership with the Mawaheb Talent Hub, backed by the Department of Government Enablement. Its national development efforts included graduating a third cohort of 28 young Emiratis, selecting 15 UAE Nationals for the World Bank Group Explorers Program.

The Academy also launched the Wealth Management Institute WMI School of AI, training over 544 UAE Nationals in agentic AI, alongside three new flagship programmes focused on family offices and wealth management.

ADGM has become the jurisdiction of choice for institutions deploying capital into artificial intelligence, with more than USD 100 billion in AI-focused investment now held by entities established in the financial centre.

That concentration is anchored by MGX, the global investment platform focused on large-scale deployment of capital into artificial intelligence infrastructure and advanced technologies, which is licensed by ADGM's FSRA.

During the first half of 2026, the financial centre completed the first phase of its artificial intelligence implementation, deploying 25 business functions with AI across licensing, supervision and customer service. The rollout has reduced manual workload by more than 5,000 staff hours annually, accelerated approval timelines and enabled approximately 25% of customer enquiries to be resolved instantly through digital channels.

Alongside these deployments, ADGM is strengthening the data, governance, cybersecurity and workforce foundations required to scale AI responsibly.

Under a technology roadmap extending to 2029, ADGM will invest more than AED 400 million to expand these capabilities, positioning the centre to regulate and serve an increasingly AI-driven financial industry.

ADGM has continued to deepen its international engagement this year. During the first half, ADGM expanded its outreach across key Asian markets including China, India and Singapore, while a strategic partnership with Shenzhen's Futian District. A strategic engagement with Italy, led by ADGM's Chairman, supported increased collaboration across investment, financial services and institutional partnerships.

ADGM also maintained a prominent presence in the US through its participation in the Milken Institute Global Conference 2026, where engagements with leading global financial institutions, including Bain Capital, Vista Equity Partners and Man Group, explored opportunities for deeper collaboration and expansion within Abu Dhabi's financial ecosystem.

ADGM also advanced a series of regulatory enhancements during H1 2026. The Registration Authority of ADGM introduced an integrated suite of real estate services, alongside the launch of a new Broker Classification Framework. The RA also published a discussion paper seeking stakeholder feedback on proposed guidance for crypto mining activities as well as amendments to ADGM's commercial legislation to enhance regulatory clarity, strengthen beneficial ownership requirements.

The Financial Services Regulatory Authority (FSRA) of ADGM advanced enhancements to its regulatory framework for insurance, aligning with International Association of Insurance Supervisors standards, and introducing requirements for the management of climate-related financial risks by relevant firms. It also finalised its regulatory framework for the staking of virtual assets, and finalised enhancements to ADGM's anti-money laundering framework to reflect developments in federal legislation and the recommendations of the Financial Action Task Force (FATF).

The first half also witnessed updates to the published Anti-Money Laundering and Sanctions Rulebook in May 2026.

International regulatory cooperation also remained a priority, with the FSRA signing an MoU with Greece's Hellenic Capital Market Commission (HCMC), Virtual Asset Regulatory Authority (VARA), Shenzhen's Futian District, and the Central Bank of Brazil.

ADGM Courts' record-breaking caseload in 2026 reflects growing confidence in its independent, internationally recognised judicial framework. By July 1, ADGM Courts had already exceeded its total caseload for the whole of 2025 and is tracking to more than double last year's caseload.

Moreover, the International Arbitration Centre Alliance launched its Global Passport, enabling recognised members of participating international dispute resolution centres to access shared facilities and services across jurisdictions.

As it builds on the momentum achieved during the first half of 2026, ADGM remains focused on strengthening Abu Dhabi's position as the 'Capital of Capital' and enabling sustainable economic diversification.

SOURCE ADGM

Share this article

El crecimiento internacional de GAC se acelera: las exportaciones de agosto alcanzaron las 26.978 unidades

El crecimiento internacional de GAC se acelera: las exportaciones de agosto alcanzaron las 26.978 unidades, un 177 % más que el año anterior

GUANGZHOU, China, 8 de septiembre de 2026 /PRNewswire/ -- En agosto, GAC continuó registrando un fuerte crecimiento en sus mercados internacionales, con excelentes resultados: las exportaciones de sus marcas propias alcanzaron las 26.978 unidades, lo que representa un aumento interanual del 177 %; las exportaciones acumuladas de enero a agosto llegaron a las 172.008 unidades, un 136 % más que el año anterior. Las exportaciones acumuladas de GAC hasta la fecha se acercan a las 600.000 unidades.

En América, las ventas en terminales crecieron un 93 % interanual en agosto, con varios mercados registrando un crecimiento exponencial. En julio, GAC logró un hito histórico en Uruguay, ubicándose por primera vez en el quinto lugar entre todas las marcas de vehículos de pasajeros y en el tercer lugar entre las marcas de vehículos eléctricos puros, alcanzando una cuota de mercado mensual del 6,0 %. Por su parte, el AION V se posicionó en segundo lugar en ventas generales de SUV y en primer lugar en ventas de SUV compactos en Uruguay durante julio.

En el sudeste asiático, las ventas en terminales crecieron un 24 % interanual en agosto. En Filipinas, las ventas aumentaron un 283 % interanual; en Singapur, un 89 %; en Tailandia, un 27 %; y en Indonesia, un 24 %. El mercado de Hong Kong tuvo un desempeño excepcional, con el GAC E9 como el monovolumen de lujo más vendido en julio. De enero a julio, las ventas acumuladas se ubicaron en segundo lugar entre las marcas chinas y en tercer lugar en general en Hong Kong.

África se consolidó este mes como el mercado internacional de mayor crecimiento para GAC, con un aumento del 881 % en las ventas minoristas de agosto en comparación con el año anterior. GAC International continuó fortaleciendo su presencia en África y firmó con éxito un acuerdo de producción local en Egipto con Jameel Motors. GAC entró oficialmente en Ghana y presentó una gama de modelos insignia, entre los que se incluyen el S7, el GS8 y el AION V.

En Oriente Medio, GAC ha mantenido una tendencia de crecimiento constante y se ha ganado la confianza de más de 100.000 usuarios en la región. El 28 de agosto, GAC presentó en el extranjero el XT80, el primer vehículo todoterreno de la marca, junto con el GS7 PHEV. El lanzamiento del GS7 PHEV en Oriente Medio está previsto para septiembre.

Las ventas minoristas en Europa crecieron un 93 % intermensual en agosto, con un aumento del 89 % en el Reino Unido, del 167 % en Portugal y del 33 % en Polonia. Grecia destacó al ocupar el segundo lugar en ventas de vehículos eléctricos puros en agosto, aumentando constantemente su cuota de mercado.

Los impresionantes resultados no solo son un poderoso testimonio de los logros graduales de GAC en su expansión internacional, sino también un claro ejemplo de cómo las marcas automovilísticas chinas llegan al mercado global y se ganan el reconocimiento de los usuarios en todo el mundo.

Para obtener más información sobre GAC, visite: https://www.gacgroup.com/en o síganos en las redes sociales.

Share this article

TMC TONGXIN MICRO Showcases Solutions for Digital Finance and Trusted Identity at Seamless Africa 2026

JOHANNESBURG and BEIJING, Sept. 8, 2026 /PRNewswire/ -- At Seamless Africa 2026, held September 8–9, Tongxin Microelectronics (TMC TONGXIN MICRO), a provider of security chip solutions, showcased technologies for payment IC cards, payment terminals and electronic identity documents.

Payment IC Cards

The company presented its Payment Product THD89 Family, the first China-developed security chip to achieve CC EAL6+ certification. The series is widely used in payment cards supporting major networks including UnionPay, Visa, Mastercard, and JCB, securing transactions for hundreds of millions of cardholders.

TMC TONGXIN MICRO also presented the E450R, the world's first open architecture security chip. Built on RISC-V open hardware and the OpenPlatform software architecture, the E450R provides an open foundation for the development of financial payment applications. Already adopted by state-owned and joint-stock banks in China, with tens of millions of units produced and deployed, the chip represents a significant advance in open innovation within the financial payments industry.

Payment Terminal Solutions

The Secure MCU Series from TMC TONGXIN MICRO is fully certified to the global payment industry's PCI PTS 7.x and UnionPay's UPTS 3.0 standards. This compliance enables widespread deployment in smart POS systems, mPOS devices, fingerprint-enabled USB security tokens, U-Keys and integrated MIS terminals. Already commercially adopted in large volumes across domestic and international financial equipment markets, these solutions ensure end-to-end security for terminal devices across the entire financial transaction process.

Digital Identity & eDocuments

TMC TONGXIN MICRO's identity portfolio combines world-class hardware and software security protections and has passed rigorous testing by FIME, a globally recognized security testing laboratory. Available in a range of formats, including contactless modules, dual-interface modules, inlays, complete cards and passport booklets, the solutions serve national IDs, e-passports, and digital driver's licenses. To date, this technology has protected the digital identities of more than 1 billion citizens worldwide.

With 24 years of R&D and commercialization experience, TMC TONGXIN MICRO has shipped over 27 billion chips globally, supporting applications from financial payments to national identity frameworks. In Africa, it contributes to the development of digital economy and identity security with innovative technologies. The company continues to work with industry partners to deliver secure and accessible technology that improves daily life.

For more information about Tongxin Microelectronics, please visit: www.tsinghuaic.com

Share this article

HYDERABAD, India, Sept. 8, 2026 /PRNewswire/ -- Mordor Intelligence has published a new report on the certificate authority market, providing a comprehensive assessment of market dynamics, technology trends, competitive landscape, and future opportunities. According to the study, the certificate authority market size is estimated to grow from USD 232.31 million in 2026 to USD 397.14 million by 2031, registering a CAGR of 11.32% during the forecast period (2026–2031). The market is being shaped by shorter certificate lifecycles, growing machine-identity requirements, cloud-based public key infrastructure (PKI), DevSecOps-led automation, stringent cybersecurity regulations, and the increasing need to secure digital transactions and connected systems.

The continued expansion of cloud-native infrastructure and zero-trust architecture is increasing demand for secure digital identities, while shorter certificate lifecycles are pushing organizations toward automated issuance, renewal, and monitoring. At the same time, growing adoption of cloud-based PKI and DevSecOps workflows is enabling faster certificate provisioning and creating opportunities for providers supporting multi-cloud environments, machine identities, and high-volume certificate management.

Certificate Authority Market Trends Driving Automated Digital Trust

Shorter Certificate Lifecycles Accelerate Certificate Automation

Shorter certificate validity periods are increasing the frequency of certificate issuance, renewal, replacement, and revocation, making manual management increasingly difficult. Enterprises are therefore adopting automated certificate lifecycle platforms integrated with DevSecOps and CI/CD pipelines to monitor inventories, trigger renewals, and distribute certificates across growing cloud, application, API, and microservice environments.

Cloud-Based PKI Expands Across Enterprise Infrastructure

Cloud-based PKI is gaining adoption as organizations increasingly manage certificate issuance through APIs, infrastructure-as-code, and automated deployment workflows. The approach simplifies certificate lifecycle management across hybrid and multi-cloud environments while reducing reliance on physical infrastructure, although concerns around vendor lock-in, certificate portability, and centralized control may influence enterprise procurement decisions.

DevSecOps and Machine Identity Drive Certificate Automation

The expansion of DevSecOps, containers, APIs, microservices, and zero-trust architecture is increasing demand for automated certificate issuance and machine-identity management. Organizations require platforms that can dynamically issue and rotate short-lived certificates, discover and monitor certificate inventories, enforce policies, and manage authentication across large volumes of applications, workloads, devices, and machine-to-machine connections.

Ashish Gautam, Senior Research Manager, Mordor Intelligence, says, "Organizations evaluating opportunities in the Certificate Authority Market need research that clearly captures the shift toward automated certificate management, cloud-based PKI, and growing machine-identity requirements. Mordor Intelligence combines extensive primary research with rigorous secondary analysis to provide balanced, evidence-based insights that support informed business decisions across the evolving digital trust landscape."

Check out more details and stay updated with the latest industry trends, including the Japanese version for localized insights: https://www.mordorintelligence.com/ja/industry-reports/certificate-authority-market?utm_source=prnewswire

Geographic Analysis of the Certificate Authority Market

North America retained a leading position in the Certificate Authority Market, supported by mature cybersecurity infrastructure, widespread cloud adoption, zero-trust initiatives, and stringent regulatory requirements. Enterprises and government organizations are increasingly using digital certificates across devices, workloads, APIs, applications, and secure communications. Growing cybersecurity investments and payment-security requirements are further supporting demand for automated certificate management.

Asia-Pacific is expected to be the fastest-growing regional market, driven by expanding cloud adoption, digital payments, mobile commerce, connected devices, and government digitalization initiatives. Countries such as China, India, Japan, and South Korea are witnessing increasing demand for secure digital transactions, digital identity infrastructure, cloud applications, and connected systems.

Europe remains strategically important due to its extensive regulatory framework covering digital trust, cybersecurity, and qualified trust services. The implementation of eIDAS 2.0 is supporting the development of cross-border digital identity and trust services, while organizations across regulated industries continue to strengthen certificate governance, authentication, and digital trust infrastructure.

Table of Contents (Partial) – Certificate Authority Industry

- INTRODUCTION

1.1 Study Assumptions and Market Definition

1.2 Scope of the Study

- RESEARCH METHODOLOGY

- EXECUTIVE SUMMARY

- MARKET LANDSCAPE

4.1 Market Overview

4.2 Market Drivers

4.2.1 Growing Awareness of Secure Web Access

4.2.2 Stringent Regulations and Compliance Mandates

4.2.3 Surge in E-Commerce and Online Transactions

4.2.4 Expansion of Cloud-Based PKI Services

4.2.5 DevSecOps-Led Certificate Automation

4.2.6 Machine-Identity Demand in Zero-Trust Networks

4.3 Market Restraints

4.3.1 Low Security-Certificate Awareness in Emerging SMBs

4.3.2 Prevalence of Self-Signed Certificates

4.3.3 Certificate Lifecycle Complexity at Hyperscale

4.3.4 Regulatory Uncertainty on Post-Quantum Standards

4.4 Evaluation of Critical Regulatory Framework

4.5 Industry Value Chain Analysis

4.6 Technological Outlook

4.7 Porter's Five Forces Analysis

- MARKET SIZE AND GROWTH FORECASTS (VALUE)

5.1 By Component

5.1.1 Certificate Types

5.1.1.1 SSL/TLS Certificates

5.1.1.2 Code-Signing Certificates

5.1.1.3 Secure Email Certificates

5.1.1.4 Authentication Client Certificates

5.1.2 Services

5.2 By Organization Size

5.2.1 Large Enterprises

5.2.2 Small and Medium Enterprises

5.3 By End-User Vertical

5.3.1 BFSI

5.3.2 IT and Telecom

5.3.3 Retail and E-Commerce

5.3.4 Healthcare and Life Sciences

5.3.5 Government and Public Sector

5.4 By Certificate Validation Level

5.4.1 Domain Validation

5.4.2 Organization Validation

5.4.3 Extended Validation

5.5 By Deployment Model

5.5.1 On-Premise

5.5.2 Cloud

5.6 By Geography

5.6.1 North America

5.6.2 South America

5.6.3 Europe

5.6.4 Asia Pacific

5.6.5 Middle East and Africa

- COMPETITIVE LANDSCAPE

6.1 Market Concentration

6.2 Strategic Moves

6.3 Market Share Analysis

6.4 Company Profiles

- MARKET OPPORTUNITIES AND FUTURE OUTLOOK

7.1 White-Space and Unmet-Need Assessment

For details on other market segments and the full table of contents, visit: https://www.mordorintelligence.com/industry-reports/certificate-authority-market?utm_source=prnewswire

Related Reports by Mordor Intelligence

Enterprise Key Management (EKM) Market Report

The Enterprise Key Management Market is expected to reach USD 3.46 billion in 2026 and is forecast to reach USD 9.26 billion by 2031, registering a 21.76% CAGR. Growth is driven by rising regulatory mandates for data encryption, increasing cloud and IoT workloads, and the shift toward hybrid and multi-cloud architectures. Growing adoption of centralized key management and post-quantum cryptography readiness is also supporting market expansion.

Network Encryption Market Outlook

The Network Encryption Market is expected to reach USD 5.67 billion in 2026 and is forecast to reach USD 8.37 billion by 2031, registering an 8.12% CAGR. Growth is supported by increasing cyber threats, expanding data transmission across networks, and the adoption of cloud and connected technologies. Organizations are also strengthening encryption capabilities to protect sensitive data and secure digital communications.

Identity Verification Market Data

The Identity Verification Market is expected to reach USD 15.78 billion in 2026 and is forecast to reach USD 26.8 billion by 2031, registering an 11.18% CAGR. Growth is driven by increasing digital transactions, rising identity fraud concerns, and expanding online services requiring secure authentication. Regulatory requirements and the adoption of digital identity solutions across financial services, healthcare, and other industries are further supporting market growth.

About Mordor Intelligence

Mordor Intelligence is a trusted partner for businesses seeking comprehensive and actionable market intelligence. Its global reach, expert team, and tailored solutions empower organizations and individuals to make informed decisions, navigate complex markets, and achieve their strategic goals.

With a team of more than 550 domain experts and on-ground specialists spanning 150+ countries, Mordor Intelligence provides syndicated and custom research covering a wide range of industries, including aerospace and defense, agriculture, animal nutrition and wellness, automation, automotive, chemicals and materials, consumer goods and services, electronics, energy and power, financial services, food and beverages, healthcare, hospitality and tourism, information and communications technology, investment opportunities, and logistics.

For inquiries, please contact:

[email protected]

https://www.mordorintelligence.com/contact-us

SOURCE Mordor Intelligence Private Limited

Share this article

HONG KONG, Sept. 8, 2026 /PRNewswire/ -- RedotPay, a global stablecoin payments company, today announced the receipt of an independent review on its AML/CFT controls and processes conducted by a Big Four firm.

The review evaluated the company's licensed Hong Kong subsidiaries*' AML/CFT controls and processes against the relevant guidelines issued by the Hong Kong Companies Registry. Its scope covered end-to-end compliance processes, including governance, quality assurance, customer due diligence (CDD), transaction monitoring, and internal staff training and resourcing.

The independent review confirms that RedotPay's processes and controls are capable of identifying, assessing, and managing financial crime risk. It also provides RedotPay with an external perspective on its AML/CFT framework which will help inform the company's ongoing work to strengthen controls as its products, operations, and regulatory obligations evolve.

"All stablecoin payments firms have a sole responsibility to operate with strong safeguards and clear accountability," said a RedotPay spokesperson. "We welcome independent scrutiny because it helps us continuously assess and improve the controls that support our users, partners, and the broader payments ecosystem."

The announcement comes as stablecoin-powered payments become increasingly integrated with payment, card, and financial-services infrastructure. RedotPay expects stablecoin-powered cards to reach $50 billion in annualized spend by 2028, underscoring the importance of robust AML/CFT controls as the sector scales.

RedotPay's AML/CFT framework is designed to identify, assess, and manage financial-crime risk across its business. The company will continue investing in its compliance controls and working with relevant regulators and partners as the policy and regulatory landscape for stablecoins and digital payments develops.

About RedotPay

RedotPay is a global stablecoin-based payment fintech that integrates blockchain solutions with traditional banking and finance infrastructures. Our intuitive platform empowers millions around the world to spend and send digital assets, ensuring faster, more accessible and inclusive financial services. RedotPay advances financial inclusion for the unbanked and supports crypto enthusiasts, driving global adoption of secure and flexible stablecoin-powered financial solutions to bring crypto to real life. For more information, visit www.redotpay.com.

*The review applied to Red Dot Trust Limited and Red F. Technology Limited.

SOURCE RedotPay

Share this article